Invitrogen on Tuesday named David Hoffmeister as chief financial officer, replacing Eric Winzer, who held the post since 2002. Winzer will remain on the Invitrogen staff and will manage the installation of enterprise resource planning for the company, typically a lengthy and expensive information technology project. Hoffmeister comes to Invitrogen after 20 years at McKinsey & Co., where he left as a senior partner specializing in mergers and acquisitions.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Women with breast or ovarian cancer living in medically underserved regions of the US are less likely to get recommended BRCA1 or BRCA2 genetic testing, according to a new study.

Three immunology researchers are to receive this year's Albany Medical Center Prize in Medicine and Biomedical Research, the Albany Times-Union reports.

In Genome Research this week: clonal evolution analysis of acute myeloid leukemia, computational pipeline to examine relationships between bacterial pathogens, and more.

Elephants may have "re-animated" a pseudogene to help stave off cancer, according to the New York Times.